Search results

  1. 1.
    0619166 - MBÚ 2026 RIV GB eng J - Journal Article
    Matušková, H. - Mařásek, P. - Mazhara, Vladyslav - Simonova, E. - Kosinová, L. - Daněk, P. - Daňová, K. - Šajnerová, K. - Malátová, I. - Hrabánková, K. - Greco, D. - Martinec, O. - Fabišik, M. - Podzimková, N. - Hladíková, K. - Běhalová, Kateřina - Antošová, Z. - Šírová, Milada - Mikysková, Romana - Reiniš, Milan - Kovář, Marek - Béchard, D. - Moebius, U. - Palová Jelínková, L. - Spíšek, R. - Steegmaier, M. - Adkins, I.
    Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v.
    Journal for ImmunoTherapy of Cancer. Roč. 13, č. 4 (2025), č. článku 10.1136/jitc-2024-010736. ISSN 2051-1426. E-ISSN 2051-1426
    R&D Projects: GA MŠMT LX22NPO5102
    Institutional support: RVO:61388971 ; RVO:68378050
    Keywords : Cytokine * Immune Checkpoint Inhibitor * Immunotherapy * T cell * Tumor microenvironment - TME
    OECD category: Immunology
    Impact factor: 10.3, year: 2023 ; AIS: 3.597, rok: 2023
    Method of publishing: Open access
    Result website:
    https://jitc.bmj.com/content/13/4/e010736DOI: https://doi.org/10.1136/jitc-2024-010736
    Permanent Link: https://hdl.handle.net/11104/0365893
     
    FileDownloadSizeCommentaryVersionAccess
    Novel PD-1-targeted.pdf03.9 MBPublisher’s postprintopen-access
     
  2. 2.
    0601919 - MBÚ 2025 RIV GB eng J - Journal Article
    Rajsiglová, Lenka - Babič, Michal - Krausová, Kateřina - Lukáč, Pavol - Kalkusová, K. - Táborská, P. - Sojka, L. - Bartůňková, J. - Stakheev, Dmitry - Vannucci, Luca - Smrž, Daniel
    Immunogenic properties of nickel-doped maghemite nanoparticles and the implication for cancer immunotherapy.
    Journal of Immunotoxicology. Roč. 21, č. 1 (2024), č. článku 2416988. ISSN 1547-691X. E-ISSN 1547-6901
    R&D Projects: GA MZd(CZ) NU23-08-00071; GA MŠMT LX22NPO5102
    Institutional support: RVO:61388971 ; RVO:61389013
    Keywords : iron-oxide nanoparticles * dendritic cells * establishment * expression * antigen * induce * death * Nanoparticles * cancer cells * immunogenic cell death * macrophages * dendritic cells * T-cells
    OECD category: Immunology; Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials (UMCH-V)
    Impact factor: 2.4, year: 2023 ; AIS: 0.548, rok: 2023
    Method of publishing: Open access
    Result website:
    https://www.tandfonline.com/doi/full/10.1080/1547691X.2024.2416988DOI: https://doi.org/10.1080/1547691X.2024.2416988
    Permanent Link: https://hdl.handle.net/11104/0359147
     
     
  3. 3.
    0598151 - MBÚ 2026 RIV US eng J - Journal Article
    Láníčková, T. - Hensler, M. - Kašíková, L. - Vošáhlíková, Š. - Angelidou, A. - Pasulka, J. - Griebler, H. - Drozenová, J. - Mojžíšová, K. - Vankerckhoven, A. - Laco, J. - Ryška, A. - Dundr, P. - Kocián, R. - Cibula, D. - Brtnický, T. - Škapa, P. - Jacob, F. - Kovář, Marek - Práznovec, I. - McNeish, I. A. - Halaška, M. J. - Rob, L. - Coosemans, A. - Orsulic, S. - Galluzzi, L. - Špíšek, R. - Fučíková, J.
    Chemotherapy drives tertiary lymphoid structures that correlate with ICI-responsive TCF1+CD8+ T cells in metastatic ovarian cancer.
    Clinical Cancer Research. Roč. 31, č. 1 (2025), s. 164-180. ISSN 1078-0432. E-ISSN 1557-3265
    R&D Projects: GA MŠMT LX22NPO5102
    Institutional support: RVO:61388971
    Keywords : Tertiary Lymphoid Structures * T Cells * Ovarian Cancer
    OECD category: Immunology
    Impact factor: 10.4, year: 2023 ; AIS: 4.113, rok: 2023
    Method of publishing: Open access
    Result website:
    https://aacrjournals.org/clincancerres/article/doi/10.1158/1078-0432.CCR-24-1594/747939/Chemotherapy-Drives-Tertiary-Lymphoid-StructuresDOI: https://doi.org/10.1158/1078-0432.CCR-24-1594
    Permanent Link: https://hdl.handle.net/11104/0355883
     
    FileDownloadSizeCommentaryVersionAccess
    Chemoterapy drives tertiary lymphoid structures.pdf512.8 MBPublisher’s postprintopen-access
     
  4. 4.
    0584603 - MBÚ 2025 RIV US eng J - Journal Article
    Kašíková, L. - Raková, J. - Hensler, M. - Láníčková, T. - Tománková, J. - Pasulka, J. - Drozenová, J. - Mojžíšová, K. - Fialová, A. - Vošahlíková, Š. - Laco, J. - Ryška, A. - Dundr, P. - Kocián, R. - Brtnický, T. - Skapa, P. - Čapková, L. - Kovář, Marek - Procházka, Jan - Práznovec, I. - Koblížek, V. - Tasková, A. - Tanaka, H. - Lischke, R. - Mendez, F. C. - Vachtenheim, J. J. - Heinzelmann-Schwarz, V. - Jacob, F. - McNeish, I. A. - Halaška, M. J. - Rob, L. - Cibula, D. - Orsulic, S. - Galluzzi, L. - Spíšek, R. - Fučíková, J.
    Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer.
    Nature Communications. Roč. 15, č. 1 (2024), s. 2528. ISSN 2041-1723. E-ISSN 2041-1723
    R&D Projects: GA MŠMT LX22NPO5102
    Institutional support: RVO:61388971 ; RVO:68378050
    Keywords : lymphoid structures * B cells * T cell * ovarian cancer
    OECD category: Immunology
    Impact factor: 14.7, year: 2023 ; AIS: 5.66, rok: 2023
    Method of publishing: Open access
    Result website:
    https://www.nature.com/articles/s41467-024-46873-wDOI: https://doi.org/10.1038/s41467-024-46873-w
    Permanent Link: https://hdl.handle.net/11104/0352493
     
    FileDownloadSizeCommentaryVersionAccess
    Tertiary lymphoid structures.pdf413.1 MBPublisher’s postprintopen-access
     
  5. 5.
    0571076 - MBÚ 2024 RIV DE eng J - Journal Article
    Holíček, P. - Truxová, I. - Raková, J. - Šálek, C. - Hensler, M. - Kovář, Marek - Reiniš, Milan - Mikyšková, Romana - Pasulka, J. - Vošahlíková, Š. - Remešová, H. - Valentová, I. - Lysák, D. - Holubová, M. - Kašpar, Petr - Procházka, Jan - Kašíková, L. - Špíšek, R. - Galluzzi, L. - Fučiková, J.
    Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
    Cell Death & Disease. Roč. 14, č. 3 (2023), č. článku 209. ISSN 2041-4889. E-ISSN 2041-4889
    R&D Projects: GA MŠMT LM2023036; GA MŠMT LX22NPO5102
    Institutional support: RVO:61388971 ; RVO:68378050
    Keywords : acute myeloid-leukemia * alpha * cells * metastasis * signature * radiation * rna
    OECD category: Immunology; Cell biology (UMG-J)
    Impact factor: 8.1, year: 2023 ; AIS: 1.997, rok: 2023
    Method of publishing: Open access
    Result website:
    https://www.nature.com/articles/s41419-023-05728-wDOI: https://doi.org/10.1038/s41419-023-05728-w
    Permanent Link: https://hdl.handle.net/11104/0342383
     
    FileDownloadSizeCommentaryVersionAccess
    Type I interferon signaling.pdf01.4 MBPublisher’s postprintopen-access
     
  6. 6.
    0563741 - MBÚ 2023 RIV CH eng J - Journal Article
    Antošová, Z. - Podzimkova, N. - Tomala, Jakub - Augustýnková, K. - Sajnerová, K. - Nedvědová, E. - Šírová, Milada - de Martynoff, G. - Bechard, D. - Moebius, U. - Kovář, Marek - Špíšek, R. - Adkins, I.
    SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity.
    Frontiers in Immunology. Roč. 13, OCT 10 2022 (2022), č. článku 989895. ISSN 1664-3224. E-ISSN 1664-3224
    Institutional support: RVO:61388971
    Keywords : NK cells * antibody-dependent cytotoxicity * interleukin-15 * immunotherapy * therapeutic antibodies * rli-15
    OECD category: Oncology
    Impact factor: 7.3, year: 2022 ; AIS: 1.765, rok: 2022
    Method of publishing: Open access
    Result website:
    https://www.frontiersin.org/articles/10.3389/fimmu.2022.989895/fullDOI: https://doi.org/10.3389/fimmu.2022.989895
    Permanent Link: https://hdl.handle.net/11104/0335572
     
  7. 7.
    0544091 - ÚI 2022 RIV US eng J - Journal Article
    Cibula, D. - Rob, L. - Mallmann, P. - Knapp, P. - Klat, J. - Chovanec, J. - Minář, L. - Melichar, B. - Hein, A. - Kieszko, D. - Pluta, M. - Špaček, J. - Bartoš, P. - Wimberger, P. - Madry, R. - Markowska, J. - Streb, J. - Valha, P. - Bin Hassan, H. I. - Pecen, Ladislav - Galluzzi, L. - Fučíková, J. - Hrnčiarová, T. - Hraška, M. - Bartůňková, J. - Spíšek, R.
    Dendritic Cell-based Immunotherapy (DCVAC/OvCa) Combined with Second-line Chemotherapy in Platinum-sensitive Ovarian Cancer (SOV02): A Randomized, Open-label, Phase 2 Trial.
    Gynecologic Oncology. Roč. 162, č. 3 (2021), s. 652-660. ISSN 0090-8258. E-ISSN 1095-6859
    Institutional support: RVO:67985807
    Keywords : Ovarian cancer * Dendritic-cell based immunotherapy * Immunogenic cell death
    OECD category: Oncology
    Impact factor: 5.304, year: 2021 ; AIS: 1.432, rok: 2021
    Method of publishing: Open access
    Result website:
    http://dx.doi.org/10.1016/j.ygyno.2021.07.003DOI: https://doi.org/10.1016/j.ygyno.2021.07.003
    Permanent Link: http://hdl.handle.net/11104/0321150
     
    FileDownloadSizeCommentaryVersionAccess
    054409-aaccoa.pdf21.5 MBOA CC BY 4.0Publisher’s postprintopen-access
     
  8. 8.
    0542897 - MBÚ 2022 RIV US eng J - Journal Article
    Raková, J. - Truxová, I. - Holicek, P. - Šálek, C. - Hensler, M. - Kašíková, L. - Pasulka, J. - Holubová, M. - Kovář, Marek - Lysák, D. - Kline, J. P. - Ráčil, Z. - Galluzzi, L. - Spíšek, R. - Fučíková, J.
    TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients.
    Oncoimmunology. Roč. 10, č. 1 (2021), č. článku 1889822. ISSN 2162-402X. E-ISSN 2162-402X
    Institutional support: RVO:61388971
    Keywords : Co-inhibitory receptor * innate lymphoid cells * lag-3 * tigit * vista
    OECD category: Microbiology
    Impact factor: 7.723, year: 2021 ; AIS: 1.796, rok: 2021
    Method of publishing: Open access
    Result website:
    https://www.tandfonline.com/doi/full/10.1080/2162402X.2021.1889822DOI: https://doi.org/10.1080/2162402X.2021.1889822
    Permanent Link: http://hdl.handle.net/11104/0320233
     
  9. 9.
    0542896 - MBÚ 2022 RIV NL eng J - Journal Article
    Sivák, Ladislav - Šubr, Vladimír - Kovářová, Jiřina - Dvořáková, Barbora - Šírová, Milada - Říhová, Blanka - Randárová, Eva - Kraus, Michal - Tomala, Jakub - Studenovský, Martin - Vondráčková, Michaela - Sedláček, Radislav - Makovický, Peter - Fučíková, J. - Vošahlíková, Š. - Spíšek, R. - Kostka, Libor - Etrych, Tomáš - Kovář, Marek
    Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling.
    Journal of Controlled Release. Roč. 332, APR 10 2021 (2021), s. 563-580. ISSN 0168-3659. E-ISSN 1873-4995
    R&D Projects: GA ČR(CZ) GA19-05649S; GA MŠMT(CZ) LM2015040; GA MŠMT(CZ) ED1.1.00/02.0109
    Research Infrastructure: CCP - 90040
    Institutional support: RVO:61388971 ; RVO:61389013 ; RVO:68378050
    Keywords : Ritonavir derivate * Polymer carrier * pH-controlled release * Antitumor activity * Proteasome inhibition * STAT3 signaling inhibition
    OECD category: Microbiology; Polymer science (UMCH-V)
    Impact factor: 11.467, year: 2021 ; AIS: 1.655, rok: 2021
    Method of publishing: Limited access
    Result website:
    https://www.sciencedirect.com/science/article/pii/S0168365921001267DOI: https://doi.org/10.1016/j.jconrel.2021.03.015
    Permanent Link: http://hdl.handle.net/11104/0320232
     
    FileDownloadSizeCommentaryVersionAccess
    Polymer-ritonavir derivate nanomedicine.pdf111.3 MBPublisher’s postprintrequire
     
  10. 10.
    0505825 - MBÚ 2020 RIV CH eng J - Journal Article
    Funda, David P. - Palová-Jelinková, L. - Goliáš, Jaroslav - Kroulíková, Zuzana - Fajstová, Alena - Hudcovic, Tomáš - Spíšek, R.
    Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?
    Frontiers in Immunology. Roč. 10, MAY 14 (2019), č. článku 967. ISSN 1664-3224. E-ISSN 1664-3224
    R&D Projects: GA MZd(CZ) NV16-27994A
    Institutional support: RVO:61388971
    Keywords : type 1 diabetes * cell therapy * animal models
    OECD category: Microbiology
    Impact factor: 5.085, year: 2019 ; AIS: 1.581, rok: 2019
    Method of publishing: Open access
    Result website:
    https://www.frontiersin.org/articles/10.3389/fimmu.2019.00967/fullDOI: https://doi.org/10.3389/fimmu.2019.00967
    Permanent Link: http://hdl.handle.net/11104/0297201
     
    FileDownloadSizeCommentaryVersionAccess
    151-Optimal Tolerogenic Dendritic Cells.pdf52.1 MBPublisher’s postprintrequire
     

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.